We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Third Point Investors Ltd (TPOU) Ordinary NPV USD

Sell:$23.00 Buy:$23.40 0 Change: $1.40 (6.33%)
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.40 (6.33%)
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.40 (6.33%)
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.


To provide its Shareholders with consistent long term capital appreciation, utilising the investment skills of the Investment Manager, through investment of all of its capital through a master-feeder structure in shares of Third Point Offshore Fund, Ltd.

Top 10 holdings currently unavailable.

Top 10 sectors currently unavailable.

Top 10 countries currently unavailable.

Fee Structure

A management fee of 1.25% p.a. of the NAV and the incentive fee of 20% on the NAV growth invested in the Master Partnership of the Master Fund. Agreement terminable on notice period of 24 months.

Dividend Policy

As announced on 1 March 2018, the Board, after consultation with major Shareholders, resolved that the Company would stop paying dividends.


Total number of holdings: 0.

Trust Manager

Daniel Loeb

Manager Bio

Daniel S. Loeb is CEO of Third Point LLC, a New York-based asset management firm founded in 1995. Third Point invests in equity and credit securities in U.S. and international markets. The firm often engages with company management and boards to improve performance and will also take passive stakes in companies with a long-term view of value creation. In addition to offering behind-the-scenes advice to numerous companies, Daniel has served on five publicly traded company boards: Ligand Pharmaceuticals; POGO Producing Co.; Massey Energy; Yahoo!; and Sotheby’s, where he helped oversee the successful sale of the company. Daniel’s philanthropic activities are driven by principles of individual human rights, including fighting against inequality and discrimination and for policies that lead to greater economic opportunity for all. For over a decade, he has been an advocate for reforming America’s schools to ensure all children have access to high quality education, fixing the country’s broken criminal justice system, and advancing freedom for LGBT individuals. He is a strong supporter of Jewish and Israel causes. Mr. Loeb is a trustee of the Mount Sinai Health System, where he established the Ronald M. Loeb Center for Alzheimer’s disease in memory of his late father. He is a Member of the Council on Foreign Relations and serves on the board of Success Academy Charter Schools, where he also served as board Chairman from 2014-2019. Daniel graduated from Columbia University with an A.B. in economics in 1983, endowed the Daniel S. Loeb Scholarship for undergraduate study there, and received the school’s John Jay Award for distinguished professional achievement. In October 2020, he was awarded the Alexander Hamilton Award for his philanthropic service by the Manhattan Institute.

Board Of Directors

Rupert DoreyChairman, Joshua Targoff, Vivien Gould, Richard Boleat, Claire Whittet, Huw Evans

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.